Financial Year |
March 31 2023 |
Monetary Funds |
209,460,204.13 |
Held-for-trading Financial Assets |
342,518,085.93 |
Notes Receivable |
-- |
Accounts Receivable |
144,171,812.39 |
Advances to Suppliers |
5,088,411.88 |
Other Receivables |
6,474,259.93 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
71,348,121.99 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
1,562,394.44 |
Total Current Assets |
780,623,290.69 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
-- |
Investment Properties |
-- |
Fixed Assetes |
141,534,569.39 |
Under-construction Projects |
278,533,618.85 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
20,473,217.62 |
R&D expenses |
-- |
Goodwill |
-- |
Long-Term Deferred and Prepaid Expenses |
3,071,280.65 |
Deferred Income Tax Assets |
16,202,021.57 |
Other Non-Current Assets |
36,596,212.76 |
Sub-Total of Non-Current Assets |
557,544,411.69 |
Total Assets |
1,338,167,702.38 |
Short-Term Loans |
5,000,000.00 |
Trading Financial liabilities |
-- |
Notes Payable |
-- |
Accounts Payable |
4,999,082.30 |
Accounts Received In Advance |
-- |
Employee Compensation Payable |
5,879,347.34 |
Taxes Payable |
5,353,591.36 |
Interest Payable |
-- |
Dividend Payable |
-- |
Other payables |
15,545,101.64 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
3,069,841.06 |
Other Current Liabilities |
970,492.07 |
Sub-Total of Current Liabilities |
50,703,439.40 |
Long-term Loans |
-- |
Bonds Payable |
-- |
Long-Term Accounts Payable |
-- |
Special Payable |
-- |
Estimatied Liabilities |
-- |
Deferred Income Tax Liabilities |
981,868.58 |
Other Non-Current Liabilities |
225,000.00 |
Sub-Total of Non-Current Liabilities |
10,761,586.98 |
Total Liabilities |
61,465,026.38 |
Paid-In Capital(Or Share Stock) |
60,288,000.00 |
Capital Surplus |
693,149,155.55 |
Surplus Reserve |
18,007,252.84 |
LESS:Treasury Stock |
-- |
Undistributed Profits |
504,451,634.55 |
Minority Stockholder's Interest |
-- |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,276,702,676.00 |
Owner's Equity(Stockholder's Equity) |
1,276,702,676.00 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
1,338,167,702.38 |